J. Malfetano

发表

Paclitaxel, an active agent in nonsquamous carcinomas of the uterine cervix: a Gynecologic Oncology Group Study.

R. Alvarez, P. Rose, J. Curtin, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical evidence for topotecan-paclitaxel non--cross-resistance in ovarian cancer.

M. Gore, J. Carmichael, N. Davidson, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Percutaneous gastrostomy for decompression in patients with advanced gynecologic malignancies.

M. Cunningham, J. Malfetano, C. Bromberg, 1995, Gynecologic oncology.

Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.

J. Malfetano, 1990, Gynecologic oncology.

Steroid receptor concentrations in endometrial carcinoma: effect on survival in surgically staged patients.

H. Homesley, N. Kadar, J. Malfetano, 1993, Gynecologic oncology.

Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease.

H. Homesley, N. Kadar, J. Malfetano, 1992, Gynecologic oncology.

cis-Diamminedichloroplatinum II based combination chemotherapy for the control of extensive paraaortic lymph node metastasis in cervical cancer.

M. Piver, S. Lele, J. Malfetano, 1987, Gynecologic oncology.

Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma

M. Cunningham, H. Keys, J. Malfetano, 1993, Cancer.

Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.

J. Carmichael, D. Armstrong, W. W. ten Bokkel Huinink, 1997, Seminars in oncology.

Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas.

C. Sheehan, Christine E. Sheehan, W. Szyfelbein, 2001, American journal of clinical pathology.

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.

G. Sutton, J. Blessing, J. Malfetano, 1996, Gynecologic oncology.

Oral topotecan as single-agent second-line chemotherapy in patients with advanced ovarian cancer.

G. Kristensen, R. Beckman, M. DeWitte, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expression.

H. Figge, R. Ambros, J. Malfetano, 1995, American journal of obstetrics and gynecology.

The pathogenesis of puerperal anuria and the value of renal-aspiration biopsy examination.

J. Malfetano, A. M. Siegeler, 1955, American journal of obstetrics and gynecology.

Prognostic Factors in Surgical Stage III and IV Carcinoma of the Endometrium

H. Homesley, N. Kadar, J. Malfetano, 1994, Obstetrics and gynecology.

Telomerase activity in benign endometrium and endometrial carcinoma.

T. Brien, P. Muraca, C. Lowry, 1997, Cancer research.

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study.

R. Burger, J. Thigpen, M. Brady, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.

G. Sutton, H. Homesley, J. Blessing, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Uterine cervical lymphoepithelial-like carcinoma. Absence of Epstein-Barr virus genomes.

S. Hoisington, E. Weinberg, J. Malfetano, 1993, American journal of clinical pathology.

Five-year survival for stage IC or stage I grade 3 epithelial ovarian cancer treated with cisplatin-based chemotherapy.

M. Piver, R. Hempling, J. Malfetano, 1992, Gynecologic oncology.

Adjuvant cisplatin-based chemotherapy for stage I ovarian adenocarcinoma: a preliminary report.

M. Piver, S. Lele, J. Malfetano, 1989, Gynecologic oncology.

A Phase II Trial of Medroxyprogesterone Acetate in Epithelial Ovarian Cancers: A Gynecologic Oncology Group Study

K. Hatch, B. Bundy, J. Malfetano, 1993, American journal of clinical oncology.

A Phase II Trial of Didemnin B (NSC #335319) in Patients with Previously Treated Epithelial Ovarian Cancer A Gynecologic Oncology Group Study

J. Blessing, J. Malfetano, A. Jacobs, 1993, American journal of clinical oncology.

A Phase II Trial of Gallium Nitrate (NSC #15200) in Previously Treated Ovarian Carcinoma A Gynecologic Oncology Group Study

J. Blessing, M. Adelson, J. Malfetano, 1991, American journal of clinical oncology.

Prophylactic Anticoagulation as a Possible Cause of Inguinal Lymphocyst After Radical Vulvectomy and Inguinal Lymphadenectomy

M. Piver, S. Lele, J. Malfetano, 1983, Obstetrics and gynecology.

Cisplatin-based chemotherapy for stage II ovarian adenocarcinoma: a preliminary report.

M. Piver, D. Driscoll, R. Hempling, 1990 .

Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study.

R. Buller, B. Sevin, J. Blessing, 1998, American journal of clinical oncology.

Phase II evaluation of oral trimetrexate in mixed mesodermal tumors of the uterus: a gynecologic oncology group study.

R. Burger, J. Fowler, J. Blessing, 2002, Gynecologic oncology.

Aggressive multimodality treatment for cervical cancer with paraaortic lymph node metastases.

H. Keys, J. Malfetano, 1991, Gynecologic oncology.

A phase II trial of ifosfamide and mesna in patients with advanced or recurrent mixed mesodermal tumors of the ovary previously treated with platinum-based chemotherapy: a Gynecologic Oncology Group study.

G. Sutton, H. Homesley, J. Blessing, 1994, Gynecologic oncology.

Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma.

R. Ambros, M. Cunningham, H. Keys, 1997, Gynecologic oncology.

Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva.

M. Cunningham, H. Keys, J. Malfetano, 1997, Gynecologic oncology.

Cis‐diamminedichloroplatinum (II): Second line induction chemotherapy in advanced ovarian adenocarcinoma

M. Piver, S. Lele, J. Barlow, 1983, Journal of surgical oncology.

Stage III and IV squamous cell carcinoma of the vulva.

M. Piver, Y. Tsukada, J. Malfetano, 1986, Gynecologic oncology.

A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma

M. Piver, P. Rose, F. Recio, 1993, Cancer.

Melanocytic proliferations associated with lichen sclerosus.

M. Mihm, K. Weismann, V. Prieto, 2002, Archives of dermatology.

A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.

R. Mannel, P. Rose, E. R. Broun, 1997, American journal of clinical oncology.

Splenectomy for optimal cytoreduction in ovarian cancer.

J. Malfetano, 1986, Gynecologic oncology.

Extragenital primary mixed malignant mesodermal tumor.

H. Bui, J. Malfetano, O. Solis, 1991, Gynecologic oncology.

Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus.

R. Ambros, J. Malfetano, J. Ross, 1994, The American journal of surgical pathology.

Clinicopathologic features of vulvar squamous cell carcinomas exhibiting prominent fibromyxoid stromal response.

M. Mihm, R. Ambros, J. Malfetano, 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Current management and treatment of squamous cell carcinoma of the vulva.

J. Malfetano, 1990, Seminars in surgical oncology.

Granular-cell myoblastoma of the vulva.

J. Malfetano, M. Marsh, T. F. Sullivan, 1954, American journal of obstetrics and gynecology.

Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous--implications for pathogenesis.

J. Carlson, E. Paunovich, J. Malfetano, 2000, The American Journal of dermatopathology.

Clinicopathologic comparison of vulvar and extragenital lichen sclerosus: histologic variants, evolving lesions, and etiology of 141 cases.

M. Mihm, J. Carlson, R. Ambros, 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia.

M. Mihm, J. Carlson, H. Figge, 1998, Human pathology.

Possible Mechanisms of Hypopigmentation in Lichen Sclerosus

J. Carlson, A. Slominski, A. del Rosario, 2002, The American Journal of dermatopathology.

Vulvar Malignant Melanoma Associated With Human Papillomavirus DNA: Report of Two Cases and Review of Literature

J. Carlson, J. Malfetano, A. Rohwedder, 2002, The American Journal of dermatopathology.

Concordant p53 and mdm-2 Protein Expression in Vulvar Squamous Cell Carcinoma and Adjacent Lichen Sclerosus

V. L. Wilson, V. Wilson, B. Selkin, 2001, Applied immunohistochemistry & molecular morphology : AIMM.

Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin.

V. L. Wilson, V. Wilson, J. Carlson, 2000, The American journal of pathology.

Cell Proliferation‐Associated Proteins in Endometrial Carcinomas, Including Papillary Serous and Endometrioid Subtypes

C. Sheehan, B. Kallakury, R. Ambros, 1998, International Journal of Gynecological Pathology.

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

B N Bundy, W. Sause, B. Bundy, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Para-endocrine hypercalcemia and ovarian small cell carcinoma.

E. Degnan, J. Malfetano, R. Florentin, 1990, New York state journal of medicine.

Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53

J. Figge, B. Kallakury, H. Figge, 1994, Cancer.

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

A Gordon, M. Gore, J. Carmichael, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-neoplastic epithelial alterations of the vulva: recognition assessment and comparisons of terminologies used among the various specialties.

M. Mihm, J. Carlson, R. Ambros, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

J. Nemunaitis, A. Rosemurgy, J. Primrose, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study.

M. E. King, T. Roy, B. Mychalczak, 2005, Gynecologic oncology.

Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma.

J. Goldkrand, J. Malfetano, 1990, Obstetrics and gynecology.

Determinants of Survival of Surgically Staged Patients With Endometrial Carcinoma Histologically Confined to the Uterus: Implications for Therapy

H. Homesley, N. Kadar, J. Malfetano, 1992, Obstetrics and gynecology.

A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer.

A. Oza, M. Gore, J. Carmichael, 2002, European journal of cancer.

Incidental cholecystectomy in the treatment of gynecologic malignancy.

J. Malfetano, R. MacDowell, M. O'Hare, 1990, Journal of gynecologic surgery.

Postpartum thrombophlebitis of the ovarian vein.

J. Malfetano, E. Bloch, N. Montalto, 1969, Obstetrics and gynecology.

Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma.

T. Rosano, J. Malfetano, T. Nazeer, 1992, American journal of clinical pathology.

Cytokine, cell adhesion receptor, and tumor suppressor gene expression in vulvar squamous carcinoma: correlation with prominent fibromyxoid stromal response.

M. Mihm, B. Kallakury, R. Ambros, 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Villoglandular adenocarcinoma of the endometrium.

R. Ambros, J. Malfetano, 2000, The American journal of surgical pathology.

Echinomycin (NSC 526417) in recurrent and metastatic nonsquamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.

H. Muss, P. Hanjani, J. Blessing, 1992, American journal of clinical oncology.

5-fluorouracil and low-dose leucovorin in the treatment of recurrent squamous cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.

E. Partridge, H. Muss, J. Blessing, 1992, American journal of clinical oncology.

Etidronate therapy decreases the sensitivity of bone scanning with methylene diphosphonate labelled with technetium-99m.

B. Line, K. J. Murphy, J. Malfetano, 1997, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.

Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content.

R. Ambros, J. Malfetano, F. Ballouk, 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.

T. Rosano, R. Ambros, J. Malfetano, 1994, Modern Pathology.

Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.

P. Muraca, M. Riben, R. Ambros, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.

J. Figge, C. Sheehan, E. Paunovich, 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Experience with carbon dioxide laser in female genital neoplasia.

J. Malfetano, A. C. Marín, 1980, Arizona medicine.

Univariate and multivariate analyses of 5‐year survival, recurrence, and inguinal node metastases in stage I and II vulvar carcinoma

M. Piver, P. Reese, Y. Tsukada, 1985, Journal of surgical oncology.

Clinical-pathologic study of stage IIB, III, and IVA carcinoma of the cervix: extended diagnostic evaluation for paraaortic node metastasis--a Gynecologic Oncology Group study.

B. Bundy, T. Okagaki, P. Heller, 1990, Gynecologic oncology.

Skin metastases from cervical cancer: a fatal event.

J. Malfetano, 1986, Gynecologic oncology.

Echinomycin (NSC 526417) in Squamous‐Cell Carcinoma of the Cervix: A Phase II Trial of the Gynecologic Oncology Group

H. Muss, J. Blessing, J. Malfetano, 1990, American journal of clinical oncology.

Peripheral infusion ports for central venous access in patients with gynecologic malignancies.

J. Malfetano, D. Kredentser, Mary J. Cunningham, 1996, Gynecologic oncology.